Cargando…
Current Pharmacological Treatment Options for Central Serous Chorioretinopathy: A Review
Central serous chorioretinopathy (CSC) is a common cause of visual impairment in patients generally aged 20 to 60 and it is characterized by acute or chronic neurosensory detachments of the retina. Although CSC resolves spontaneously in most cases, in some patients it may cause permanent visual impa...
Autores principales: | Nicolò, Massimo, Ferro Desideri, Lorenzo, Vagge, Aldo, Traverso, Carlo Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597965/ https://www.ncbi.nlm.nih.gov/pubmed/32977380 http://dx.doi.org/10.3390/ph13100264 |
Ejemplares similares
-
The Role of Atropine in Preventing Myopia Progression: An Update
por: Chierigo, Alberto, et al.
Publicado: (2022) -
Central Serous Chorioretinopathy: Multimodal Imaging and Management Options
por: Iyer, Prashanth G., et al.
Publicado: (2020) -
The multifaceted presentation of syphilitic chorioretinitis examined by multimodal imaging: A case series
por: Ferro Desideri, Lorenzo, et al.
Publicado: (2022) -
The upcoming role of Artificial Intelligence (AI) for retinal and glaucomatous diseases
por: Ferro Desideri, Lorenzo, et al.
Publicado: (2022) -
Central serous chorioretinopathy: Treatment
por: Park, Jong Beom, et al.
Publicado: (2022)